2023/0491 - ECULIZUMAB [300 MG SOL INJ FRS]
TED · 429106-2026Award noticeawardedNo deadline given
Value
Estimated€216,933 · 216,932.88 EUR
Awarded—
WinnerAMGEN BIOFARMACEUTICA, LDA
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde Santa Maria, E.P.E. in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| ROCHE Farmacêutica Química, LDA | 22 | — | 2026-08-04 |
| GILEAD SCIENCES, LDA | 18 | — | 2026-07-28 |
| SANOFI-PRODUTOS FARMACÊUTICOS,LDA | 15 | €1,569,649 | 2026-08-04 |
| NOVARTIS FARMA - PROD.FARM SA | 11 | — | 2026-08-04 |
| JANSSEN-CILAG FARMACEUTICA LDA | 9 | €371,730 | 2026-08-04 |
Full buyer profile: what Unidade Local de Saúde Santa Maria, E.P.E. buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
ECULIZUMAB [300 MG SOL INJ FRS]
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-06-24 | 2023/0491 - ECULIZUMAB [300 MG SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 100% |
| 2026-06-02 | 2023/0491 - OCRELIZUMAB [300 MG/ 10 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 98% |
| 2026-06-24 | 2023/0491 - VEDOLIZUMAB [300 MG PÓ CONC SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 97% |
| 2026-07-07 | 2023/0491 - ATEZOLIZUMAB [1200 MG/ 20 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 97% |
| 2026-06-24 | 2023/0491 - BLINATUMOMAB [38.5 µG PÓ CONC SOL SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 96% |
| 2026-07-21 | 2023/0491 - TRASTUZUMAB [600 MG/ 5 ML SOL INJ SC FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 96% |